Union Government, Extraordinary, 2017-01-24, Part II-Section 3-Sub-Section(ii), Ref. S O 247 E

1.1 MB·English

by  Government of India

jftLVªh laö Mhö ,yö&33004@99 REGD. NO. D. L.-33004/99

vlk/kj.k
EXTRAORDINARY
Hkkx II—[k.M 3—mi&[k.M (ii)
PART II—Section 3—Sub-section (ii)
izkf/dkj ls izdkf'kr
PUBLISHED BY AUTHORITY
la- 222] ubZ fnYyh] eaxyokj] tuojh 24] 2017@ek?k 4] 1938

No. 222] NEW DELHI, TUESDAY, JANUARY 24, 2017/MAGHA 4, 1938
jlk;u vkSj moZjd ea=ky;
¼vvvvkkkk””SS””SSkkkk////kkkk ffffooooHHHHkkkkkkkkxxxx½
¼jjjjkkkk””””VVVVªªhhªªhh;;;; vvvvkkkk””SS””SSkkkk////kkkk eeeeYYwwYYww ;;;; ffffuuuu////kkkkkkkkZZjjZZjj....kkkk iiiizzkkzzkkffff////kkkkddddjjjj....kkkk½
vkns’k
ubZ fnYyh] 24 tuojh] 2017
dk-vk- 247¼v½.—jk’Vªh; vkS’k/k eYw ; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj d s jlk;u vkSj moZjd ea=ky; }kjk tkjh
dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 vkSj dk- vk- 701¼v½ rkjh[k 10 ekpZ] 2016 d s lkFk ifBr vkS’k/k ¼dher fu;a=.k½
vkn”s k] 2013 d s iSjk 4] 6] 10] 11] 14] 16] 17 vkSj 18 }kjk inz Rr “kfDr;k sa dk iz;kxs djr s gq,] uhp s dh lkj.kh d s LrHa k ¼5½
e sa fofufnZ’V vf/kdre dher dk s mDr lkj.kh d s LrHa k ¼3½ vkSj ¼4½ e s dh Øe”k% rRLFkkuh ifzof’V;k sa e sa fofufnZ’V izcyrk vkSj
bdkbZ ¼;fwuV½ lfgr ml lkj.kh d s LrHa k ¼2½ e sa dh rRLFkkuh ifzof’V e sa fofufnZ’V vuqlfwpr fofufeZfr;k sa e sa l s izR;ds dh]
LFkkuh; dj] ;fn dkbs Z gS] dk s NkMs d+ j vf/kdre dher d s #i e sa fu;r djrh gS%
lkj.kh
Ø-la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ vf/kdre dher ¼#-½
1 2 3 4 5
1. lSVªhthu diS lyw lSVªhthu -10 fexzk- 1 dSilyw 2.21
2. Qus hVkWbu dSilyw Qus hVkWbu - 300 fexzk. 1 dSilyw 3.54
3. Qus hVkWbu bZvkj diS lyw Qus hVkWbu -300 fexzk- 1 dSilyw 3.54
4. lfsQDlhe diS lyw lfsQDlhe - 200 fexzk- 1 dSilyw 13.39
5. thMksoMq hu dSilyw thMksoMq hu - 300 fexzk- 1 dSilyw 1.84
6. izkds kcktZ hu xkys h izkds kcktZ hu - 50 fexzk- 1 xkys h 41.91
7. fcVkeFs kklkus tSy fcVkeFs kklkus - 0-05% 1 xzke 0.49
8. vkes is zktkys xkys h Vkes is zktkys -10 fexzk- 1 xkys h 4.11
417 GI/2017 (1)
2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]

9. Qus hVkWbu vksjy fyD;bw M Qus hVkWbu&125 fexzk-@5 fefy 1 fefy- 0.82
10. ikWohMkWu vk;kMs hu lkWyq“ku ikWohMkWu vk;kMs hu&4% 1 fefy- 1.62
11. vkes is zktkys bUtDs “ku d s fy, vkes is zktkys &20 fexzk- 1 xzke 1.14
ikmMj
uksV %
¼d½ ljdkj }kjk bl izdkj fu;r dh xbZ vkSj vf/klfwpr dh xbZ vf/kdre dher ¼/ku LFkkuh; dj] tk s ykx w gk½sa l s
vf/kd dher ij vuqlfwpr fofufeZfr;k sa d s czkMa Ms ;k tus fsjd ;k nkus k sa :ikarjk sa dk s cps jg s vuqlfwpr fofufeZfr;k sa d s
lHkh fofuekZrk] mi;qZDr lkj.kh d s LrHa k ¼5½ e sa of.kZr vf/kdre dher ¼/ku LFkkuh; dj] tk s ykx w gk½sa l s vf/kd lHkh
,slh fofufeZfr;k sa dh dher dk v/kkes q[kh iqujh{k.k djxsa As
¼[k½ lHkh ekStnw k fuekZrkvk sa dk s mi;qZDr dfFkr vuqlfwpr fofufeZfr;k sa d s vf/kdre [kqnjk dher mi;qZDr lkj.kh d s LrHa k
¼5½ e sa fofufnZ"V vf/kdre dher LFkkuh; dj lfgr l s de g S rk]s tgk a dgha Hkh ykx w gk]s vkS"k/k ¼eYw ; fu;a=.k½ vkn's k]
2013 d s iSjkxzkQ 13¼2½ d s vuqlkj mldk s ekStnw k vf/kdre [kqnjk dher dk s cuk, j[kuk gkxs kA
¼x½ vxj fuekZrkvk sa u s mi;qZDr lkj.kh d s LrHa k ¼5½ e sa of.kZr vf/kdre dher ij ljdkj dk s okLro e sa Hkqxrku fd;k gS ;k
;g n;s gS rk s o s LFkkuh; djk sa dk s tkMs + ldr s gAS
¼?k½ vkS"k/k ¼eYw ; fu;a=.k½ vkn's k] 2013 d s iSjkxkzQ 11 e sa fn, x, izko/kkuk sa d s rgr lEcfU/kr fuekZrkvk sa dk s mi;qZDr
lkj.kh d s LrHa k ¼5½ e sa fofufnZ"V vf/kdre dher d s vk/kkj ij vuqlfwpr fofufeZfr;k sa d s iSdk sa d s fy, vf/kdre dher
fu/kkfZjr djAsa fuekZrk vkS"k/k ¼eYw ; fu;a=.k½ vkn's k] 2013 d s iSjkxzkQ 24 d s rgr QkWeZ V e sa vf/klpw uk dh rkjh[k l s
vkbZihMh,e,l d s ek/;e l s Hkjdj ,uihih, dk s ,d eYw ; lpw h tkjh djAsa rFkk mldh dkiW h jkT; vkS"kf/k fu;a=dk sa
vkSj fofuekZrk forjd dk s tkjh djAsa
¼M-½ vkS"k/k ¼eYw ; fu;a=.k½ vkn's k] 2013 d s 24 ¼4½ d s mic/a kk sa d s vuqlkj iRz ;ds QqVdj fodzsrk vkSj forjd fofuekZrk }kjk
fn, x, :i e sa ,sl s ifjlj] tgk a dkjckj dk s bl izdkj fd;k tk jgk gS fd mll s ijke'k Z d s bPNdq fdlh O;fDr d s
fy, igqpa vklku gk]s ogk a mld s fdlh lgtn`'; Hkkx ij dher lpw h vkSj iwjd lpw h] ;fn dkbs Z gk]s dk s lia znf'kr
djxs kA
¼p½ mi;qZDr lkj.kh d s LrHa k ¼5½ e sa fofufnZ"V vf/kdre dher d s fy, fofufnZ"V vuqlfwpr fofufefZr;k sa d s fofufnZ"V fofHkUu
rjhd s vkSj icz yrk l s fHkUu vxj ekStnw k fuekZrkvk sa }kjk ,d ubZ vkS"kf/k dk s ykpa djrk gS rk s ml s igy s vkS"k/k ¼eYw ;
fu;a=.k½ vkn's k] 2013 d s iSjkxzkQ 2¼u½ d s vuqlkj vk"Sk/k ¼eYw ; fu;a=.k½ vkn's k] 2013 d s rgr lpw h II e sa fofufnZ"V
QkeZ I d s ek/;e l s ,uihih, e sa eYw ; fu/kkZj.k gsrq vkons u djuk gkxs kA
¼N½ mi;qZDr vuqlfwpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh d s lEcU/k e sa fuekZrkvk sa dk s vkS"k/k ¼eYw ; fu;a=.k½
vkn's k] 2013 d s lpw h II d s QkWeZ III dk s vkbZihMh,e,l d s ek/;e l s Hkjdj ,uihih, dk s gj frekgh dh fjikVs Z izLrqr
djxs kA mi;qZDr vuqlfwpr fofufeZfr;k sa d s fuekZ.k dk s dkbs Z fuekZrk mRiknu cUn dju s dk bPNqd gk s rk s bldh lpw uk
,uihih, dk s voxr djk;xs kA bld s lEcU/k e sa vxj vuqlfwpr fofufefZr;k sa d s mRiknu vkSj vk;kr dk s cUn dju s dk
bPNqd gS rk s cUn dju s dh frfFk l s N% eghu s igy s lpw h II d s QkWeZ IV e sa Hkjdj ,uihih, dk s izLrqr djxs kA
¼t½ fofuekZrk ;k foi.ku dEiuh] mijkDs r dfFkr lkj.kh e sa n'kkZ; s vf/kdre eYw ; vkSj 'krks± dk ikyu ugh a djrh gS a rk s o s
vko';d oLrq,¡ vf/kfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk sa d s v/khu C;kt lfgr vf/kiHz kkfjr jkf'k
dk s tek dju s d s fy, nk;h gkxsa As
¼>½ bl vkn's k e sa mijkDs r lkj.kh d s LrHa k ¼2½ e sa dh rRLFkkuh izfof"V e sa fofufnZ"V ,slh fofufefZr;k as d s iSdk sa dh vf/kdre
dher fu;r gkus s d s ifj.kkeLo#i] vf/kdre vkSj [kqnjk eYw ; fu/kkZfjr vkn's k ;fn dkbs Z gk]s tk s fd bl vkn's k l s iwoZ
tkjh g,q gS] Lor% gh vf/kØe.k gk s tk;xsa As
[dk-al-a@172@40/2016@,Q@Qk- l-a 8¼40½@2016@Mhih@,uihih,-&fMoh- II]
cythr flga ] lgk;d fun's kd
MINISTRY OF CHEMICALS AND FERTILIZERS
(Department of Pharmaceuticals)
(NATIONAL PHARMACEUTICAL PRICING AUTHORITY)
ORDER
New Delhi, the 24th January, 2017
S.O. 247(E).—In exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices
Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 701(E) dated 10th March, 2016 issued by the
Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter
referred as NPPA) hereby fixes the prices as specified in column (5) of the table herein below as ceiling price exclusive of local
¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 3

tax applicable, if any, in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said
Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:
TABLE
Sl. No. Name of the Scheduled Formulation Strength Unit Ceiling Price
(Rs.)
(1) (2) (3) (4) (5)
1 Cetirizine capsule Cetirizine-10mg 1 Capsule 2.21
2 Phenytoin Capsule Phenytoin-300mg 1 Capsule 3.54
3 Phenytoin ER Capsule Phenytoin-300mg 1 Capsule 3.54
4 Cefixime Capsule Cefixime-200 mg 1 Capsule 13.39
5 Zidovudine Capsule Zidovudine-300mg 1 Capsule 1.84
6 Procarbazine Tablet Procarbazine-50mg 1 Tablet 41.91
7 Betamethasone Gel Betamethasone-0.05% 1 GM 0.49
8 Omeprazole Tablet Omeprazole-10mg 1 Tablet 4.11
9 Phenytoin Oral Liquid Phenytoin-125mg/5ml 1 ML 0.82
10 Povidone Iodine Solution Povidone Iodine-4% 1 ML 1.62
11 Omeprazole Powder for Injection Omeprazole-20mg 1 GM 1.14
Note :
(a) All manufacturers of scheduled formulations, selling the branded or generic or both the versions of scheduled
formulations at a price higher than the ceiling price (plus local taxes as applicable) so fixed and notified by the
Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in
column (5) in the above table plus local taxes as applicable, if any.
(b) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price
specified in column (5) in the above table plus local taxes as applicable, if any, shall continue to maintain the
existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013.
(c) The manufacturers may add local taxes only if they have paid actually or if it is payable to the Government on the
ceiling price mentioned in column (5) of the above said table.
(d) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in
accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph
11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of
Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug
Controller and dealers.
(e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if
any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a
manner so as to be easily accessible to any person wishing to consult the same.
(f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above
table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior
price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013.
(g) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of
production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through
IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish
information to the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in
Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.
(h) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit
the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013
read with Essential Commodities Act, 1955.
4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]

(i) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this
notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification,
stand(s) superseded.
[PN/172/40/2016/F. No. 8(40)/2016/D.P./NPPA-Div.-II]
BALJIT SINGH, Asstt Director
vkns’k
ubZ fnYyh] 24 tuojh] 2017
dk-vk- 248¼v½.—jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj d s jlk;u vkSj moZjd ea=ky; }kjk tkjh
dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 vkSj dk- vk- 701¼v½ rkjh[k 10 ekpZ] 2016 d s lkFk ifBr vkS"k/k ¼dher fu;a=.k½
vkn's k] 2013 d s iSjk 4] 6] 10] 11] 14] 16] 17 vkSj 18 }kjk iznRr 'kfDr;k sa dk iz;kxs djr s gq,] rFkk Hkkjr ljdkj d s jlk;u
vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k d s vkn's k dk- vk- 644¼v½] fnukda 2 ekpZ] 2016] dk s tgk¡ rd
mldk lEcU/k uhp s dh lkj.kh d s fofufeZr iSdk sa ls gS] mu ckrk sa d s flok; vf/kØkUr djr s gq, ftUg sa ,sl s vf/kØe.k d s iwoZ
fd;k x;k gS ;k dju s dk ykis fd;k x;k gS] uhp s dh lkj.kh d s LrHa k ¼5½ e sa fofufnZ"V rRdky izHkkoh vf/kdre dher vkSj
mDr lkj.kh d s LrHa k ¼3½ vkSj ¼4½ e sa dh Øe'k% rRLFkkuh ifzof"V;k sa es a fofufnZ"V izcyrk vkSj bdkbZ ¼;fwuV½ lfgr ml lkj.kh
d s LrHa k ¼2½ e sa dh rRLFkkuh ifzof"V e sa fofufnZ"V vuqlfwpr fofufeZfr;k sa e sa l s izR;ds dh] LFkkuh; dj] ;fn dkbs Z gS] dk s NkMs d+ j
vf/kdre dher d s :i e sa fu;r djrh g S %
lkj.kh
dz-la- vuqlwfpr fofufeZfr izcyrk bdkbZ vf/kdre
dk uke dher ¼#-½
1 2 3 4 5
1. iSjkflVkekys bUtDs 'ku iSjkflVkekys 150 fexzk-@fefy izfr iSd ¼2 fefy½ 5.98
2. MDs lkeFs kklkus bUtDs 'ku MDs lkeFs kklkus - 4 fexzk-@fefy izfr iSd ¼30 fefy½ 32.73
3. MDs lkeFs kklkus bUtDs 'ku MDs lkeFs kklkus - 4 fexzk-@fefy izfr iSd ¼20 fefy½ 24.49
4. MDs lkeFs kklkus bUtDs 'ku MDs lkeFs kklkus - 4 fexzk-@fefy izfr iSd ¼10 fefy½ 12.78
5. MDs lkeFs kklkus bUtDs 'ku MDs lkeFs kklkus - 4 fexzk-@fefy izfr iSd ¼2 fefy½ 5.28
6. ,Ycus Mktkys vksjy ,Ycus Mktkys -200 fexzk-@5 fefy 1 fefy 1.48
fyD;bw M
7. tVsa kekblhu bUtDs 'ku tVsa kekblhu - 40 fexzk-@fefy izfr iSd ¼30 fefy½ 27.65
8. tVsa kekblhu bUtDs 'ku tVsa kekblhu - 40 fexzk-@fefy izfr iSd ¼20 fefy½ 25.27
9. tVsa kekblhu bUtDs 'ku tVsa kekblhu - 40 fexzk-@fefy izfr iSd ¼10 fefy½ 16.67
10. tVsa kekblhu bUtDs 'ku tVsa kekblhu - 40 fexzk-@fefy izfr iSd ¼2 fefy½ 4.47
11. fjQES ihlhu vksjy fjQES ihlhu - 100 fexzk-@5 fefy 1 fefy 0.34
fyD;bw M
12. LVªis Vkes kblhu bUtDs 'ku LVªis Vkes kblhu - 1 xzke izfr iSd 9.28
d s fy, ikmMj
13. DykVs ªhektkys isljh DykVs ªhektkys -100 fexzk- izfr isljh 8.06
14. ftM+ ksoqMkbu$ ftM+ ksoqMkbu&300 fexzk-$ 1 xkys h 18.69
yfseoqMkbu$ ufsojkikbu yfseoqMkbu&150 fexzk-$ ufsojkikbu -
xkys h 200 fexzk-
15. ijeFs kjhu yk”s ku ijeFs kjhu -1% 1 xzke 0.84
16. vkes is zktkys dSilyw vkes is zktkys - 10 fexzk- 1 dSilyw 1.96
17. ckblkdkMs kby lqikfstVªh ckblkdkMs kby-5 fexzk- izfr lqikfstVªh 7.83
18. eSFkhyjxkes Vs ªkbu xkys h eSFkhyjxkes Vs ªkbu&0-125 fexzk- 1 xkys h 7.35
19. Qus hVkWbu dSilyw Qus hVkWbu&100 fexzk- 1 dSilyw 1.41
¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 5

20. VVs ul VkWDlkbM & izfr iSd ¼5 fefy½ 24.41
bUtDs 'ku
21. VVs ul VkWDlkbM & izfr iSd ¼0-5 fefy½ 5.53
bUtDs 'ku
22. eSFkhyiMzs uhlkys kus eSFkhyiMzs uhlkys kus &40 fexzk-@fefy 1 fefy 44.53
bUtDs 'ku
uksV %
¼d½ ljdkj }kjk bl idz kj fu;r dh xbZ vkSj vf/klfwpr dh xb Z vf/kdre dher ¼/ku LFkkuh; dj] tk s ykx w gk½sa ls vf/kd
dher ij vuqlfwpr fofufeZfr;k sa d s czkMa Ms ;k tus fsjd ;k nkus k sa :ikarjk sa dk s cps jg s vuqlfwpr fofufefZr;k sa d s lHkh
fofuekZrk] mi;qZDr lkj.kh d s LrHa k ¼5½ e sa of.kZr vf/kdre dher ¼/ku LFkkuh; dj] tk s ykx w gk½sa l s vf/kd lHkh ,slh
fofufeZfr;k sa dh dher dk v/kkes q[kh iqujh{k.k djxsa As
¼[k½ lHkh ekStnw k fuekZrkvk sa dk s mi;qDZ r dfFkr vuqlfwpr fofufeZfr;k sa d s vf/kdre [kqnjk dher mi;qZDr lkj.kh d s LrHa k ¼5½
e sa fofufnZ"V vf/kdre dher LFkkuh; dj lfgr l s de gS rk]s tgk a dgh Hkh ykx w gk]s vk"Sk/k ¼eYw ; fu;a=.k½ vkn's k]
2013 d s iSjkxzkQ 13¼2½ d s vuqlkj mldk s ekStnw k vf/kdre [kqnjk dher dk s cuk, j[kuk gkxs kA
¼x½ vxj fuekZrkvk sa u s mi;qZDr lkj.kh d s LrHa k ¼5½ e sa of.kZr vf/kdre dher ij ljdkj dk s okLro e sa Hkqxrku fd;k g S ;k
;g n;s gS rk s o s LFkkuh; djk sa dk s tkMs + ldr s gAS
¼?k½ vkS"k/k ¼eYw ; fu;a=.k½ vkn's k] 2013 d s iSjkxzkQ 11 e sa fn, x, izko/kkuk sa d s rgr lEcfU/kr fuekZrkvk sa dk s mi;qZDr lkj.kh
d s LrHa k ¼5½ e sa fofufnZ"V vf/kdre dher d s vk/kkj ij vuqlfwpr fofufeZfr;k sa d s iSdk sa d s fy, vf/kdre dher fu/kkZfjr
djAsa fuekZrk vkS"k/k ¼eYw ; fu;a=.k½ vkn's k] 2013 d s iSjkxzkQ 24 d s rgr QkWeZ V e sa vf/klpw uk dh rkjh[k l s
vkbZihMh,e,l d s ek/;e l s Hkjdj ,uihih, dk s ,d eYw ; lpw h tkjh djAsa rFkk mldh dkWih jkT; vkS"kf/k fu;a=dk sa
vkSj fofuekZrk forjd dk s tkjh djAsa
¼M-½ vkS"k/k ¼eYw ; fu;a=.k½ vkn's k] 2013 d s 24 ¼4½ d s mic/a kk sa d s vuqlkj iRz ;ds QqVdj fodzsrk vkSj forjd fofuekZrk }kjk
fn, x, :i e sa ,sl s ifjlj] tgk a dkjckj dk s bl izdkj fd;k tk jgk gS fd mll s ijke'kZ d s bPNqd fdlh O;fDr d s
fy, igpqa vklku gk]s ogk a mld s fdlh lgtn`'; Hkkx ij dher lpw h vkSj iwjd lpw h] ;fn dkbs Z gk]s dk s lia znf'kZr
djxs kA
¼p½ mi;qZDr lkj.kh d s LrHa k ¼5½ esa fofufnZ"V vf/kdre dher d s fy, fofufnZ"V vuqlfwpr fofufeZfr;k sa d s fofufnZ"V fofHkUu
rjhd s vkSj icz yrk l s fHkUu vxj ekStnw k fuekZrkvk sa }kjk ,d ub Z vkS"kf/k dk s ykpa djrk g S rk s ml s igy s vkS"k/k ¼eYw ;
fu;a=.k½ vkn's k] 2013 d s iSjkxzkQ 2¼u½ d s vuqlkj vkS"k/k ¼eYw ; fu;a=.k½ vkn's k] 2013 d s rgr lpw h II e sa fofufnZ"V QkeZ
I d s ek/;e l s ,uihih, e sa eYw ; fu/kkZj.k gsrq vkons u djuk gkxs kA
¼N½ mi;qZDr vuqlfwpr fofufeZfr;k sa dh mRiknu@vk;kr vkSj fcØh d s lEcU/k e sa fuekZrkvk sa dk s vk"Sk/k ¼eYw ; fu;a=.k½ vkn's k]
2013 d s lpw h II d s QkWeZ III dk s vkbiZ hMh,e,l d s ek/;e l s Hkjdj ,uihih, dk s gj frekgh dh fjikVs Z izLrqr djxs kA
mi;qZDr vuqlfwpr fofufeZfr;k sa d s fuekZ.k dk s dkbs Z fuekZrk mRiknu cUn dju s dk bPNdq gk s rk s bldh lpw uk ,uihih,
dk s voxr djk;xs kA bld s lEcU/k e sa vxj vuqlfwpr fofufeZfr;k sa d s mRiknu vkSj vk;kr dk s cUn dju s dk bPNqd gS
rk s cUn dju s dh frfFk l s N% eghu s igy s lpw h II d s QkWe Z IV e sa Hkjdj ,uihih, dk s izLrqr djxs kA
¼t½ fofuekZrk ;k foi.ku dEiuh] mijkDs r dfFkr lkj.kh e sa n'kkZ; s vf/kdre eYw ; vkSj 'krks± dk ikyu ugh a djrh gS a rk s o s
vko';d oLrq,¡ vf/kfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk sa d s v/khu C;kt lfgr vf/kiHz kkfjr jkf'k
dk s tek dju s d s fy, nk;h gkxsa As
¼>½ tVsa kekblhu bUtDs ”ku 40 fexzk-@fefy] MDs lkeFs kklkus bUtDs ”ku]4 fexzk-@fefy] iSjkflVkekys bUtDs ”ku]150 fexzk-@fefy
vkSj VVs ul VkWDlkbM bUtDs ”ku d s lca /a k e]sa vU; fdlh iSd vkdkj d s fy, fuekZrk viuh fofufeZfr;k sa d s fo'k’sk eYw ;
vuqekns u gsrq ,uihih, dk s lia dZ djxs kA
¼.k½ bl vkn's k e sa mijkDs r lkj.kh d s LrHa k ¼2½ e sa dh rRLFkkuh ifzof"V e sa fofufnZ"V ,slh fofufeZfr;k sa d s iSdk sa dh vf/kdre
dher fu;r gkus s d s ifj.kkeLo#i] vf/kdre vkSj [kqnjk eYw ; fu/kkfZjr vkn's k ;fn dkbs Z gk]s tk s fd bl vkn's k l s iwoZ
tkjh g,q gS] Lor% gh vf/kØe.k gk s tk;xsa As
[dk-a l-a@172@40@2016@,Q@Qk- l-a 8¼40½@2016@Mhih@,uihih,-&fMoh-- I I]
cythr flga ] lgk;d fun's kd
6 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]

ORDER
New Delhi, the 24th January, 2017
S.O. 248(E).—In exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs
(Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 701(E) dated 10th March, 2016
issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order of the
Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O.
644(E), dated 2nd March, 2016, in so far as it relates to formulation packs mentioned in the table below, except in respect
of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby
fixes the price as specified in column (5) of the table herein below as ceiling price exclusive of local tax applicable, if
any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the
strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:
TABLE
Sl. No. Name of the Scheduled Strength Unit Ceiling
Formulation Price (Rs.)
(1) (2) (3) (4) (5)
1 Paracetamol Injection Paracetamol-150mg/ml Each Pack (2ml) 5.98
2 Dexamethasone Injection Dexamethasone-4mg/ml Each Pack (30ml) 32.73
3 Dexamethasone Injection Dexamethasone-4mg/ml Each Pack (20ml) 24.49
4 Dexamethasone Injection Dexamethasone-4mg/ml Each Pack (10ml) 12.78
5 Dexamethasone Injection Dexamethasone-4mg/ml Each Pack (2ml) 5.28
6 Albendazole Oral Liquid Albendazole-200mg/5ml 1 ML 1.48
7 Gentamicin Injection Gentamicin-40mg/ml Each Pack 27.65
(30ml)
8 Gentamicin Injection Gentamicin-40mg/ml Each Pack (20ml) 25.27
9 Gentamicin Injection Gentamicin-40mg/ml Each Pack (10ml) 16.67
10 Gentamicin Injection Gentamicin-40mg/ml Each Pack (2ml) 4.47
11 Rifampicin Oral Liquid Rifampicin-100mg/5ml 1 ML 0.34
12 Streptomycin Powder for Injection Streptomycin-1gm Each Pack 9.28
13 Clotrimazole Pessary Clotrimazole-100mg Each Pessary 8.06
14 Zidovudine + Lamivudine + Zidovudine + Lamivudine + 1 Tablet 18.69
Nevirapine Tablet Nevirapine -(300mg + 150mg
+ 200mg)
15 Permethrin Lotion Permethrin-1% 1 GM 0.84
16 Omeprazole Capsule Omeprazole-10mg 1 Capsule 1.96
17 Bisacodyl Suppository Bisacodyl-5mg Per Suppository 7.83
18 Methylergometrine Tablet Methylergometrine-0.125mg 1 Tablet 7.35
19 Phenytoin Capsule Phenytoin-100mg capsule 1 capsule 1.41
20 Tetanus Toxoid injection - Each pack (5ml) 24.41
21 Tetanus Toxoid injection - Each pack (0.5ml) 5.53
22 Methylprednisolone injection Methylprednisolone-40mg/ml 1 ML 44.53
Note:
(a) All manufacturers of scheduled formulations, selling the branded or generic or both the versions of scheduled
formulations at a price higher than the ceiling price (plus local taxes as applicable) so fixed and notified by the
Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified
in column (5) in the above table plus local taxes as applicable, if any.
¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 7

(b) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling
price specified in column (5) in the above table plus local taxes as applicable, if any, shall continue to maintain
the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013.
(c) The manufacturers may add local taxes only if they have paid actually or if it is payable to the Government on
the ceiling price mentioned in column (5) of the above said table.
(d) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in
accordance with the ceiling price specified in column (5) of the above table as per provisions contained in
paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V
from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy
to State Drug Controller and dealers.
(e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price
list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business
in a manner so as to be easily accessible to any person wishing to consult the same.
(f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the
above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall
apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the
DPCO, 2013.
(g) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect
of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013
through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation
shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled
formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of
discontinuation.
(h) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to
deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control)
Order, 2013 read with Essential Commodities Act, 1955.
(i) In respect of Gentamycin injection 40mg/ml, Dexamethasone injection 4mg/ml, Paracetamol injection
150mg/ml and Tetanus toxoid injection, for any other pack size manufactured, the manufacturer shall approach
the NPPA for specific price approval for its formulations.
(j) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in
this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of
notification, stand(s) superseded.
[PN/172/40/2016/F. No. 8(40)/2016/D.P./NPPA-Div.-II]
BALJIT SINGH, Asstt. Director

Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064
and Published by the Controller of Publications, Delhi-110054.